血管外科手术部位感染预防:证据综述
本文综述了腹主动脉瘤手术或腹股沟下动脉手术中预防术后手术部位感染的证据。共纳入21种技术和81项研究,使用GRADE指南评估证据质量。预防性抗生素和负压伤口治疗具有高质量证据支持其有效性,而许多其他技术的证据质量较低或存在偏倚风险。
要点
- 预防性抗生素和术后负压伤口治疗是预防手术部位感染的有效措施。
- 许多预防技术的证据质量低或非常低,且存在显著偏倚风险。
- 需要进一步研究庆大霉素胶原植入物和特定联合疗法的疗效。
核心结论
- 预防性抗生素和术后负压伤口治疗在腹主动脉瘤或腹股沟下动脉手术中能有效预防术后手术部位感染。
研究设计与样本
- 扩展文献综述,纳入81项临床试验,检索Ovid MEDLINE(1950年至2020年3月13日),使用GRADE指南评估证据质量。
主要发现
- 预防性抗生素和负压伤口治疗具有高质量证据支持其预防手术部位感染。
- 庆大霉素胶原植入物有中等质量证据支持(限于高手术部位感染风险中心)。
- 联合疗法、血糖控制、耐甲氧西林金黄色葡萄球菌筛查和可吸收缝线的证据质量低或非常低。
- 营养补充、氯己定沐浴、备皮疗法、金黄色葡萄球菌鼻腔清除、氰基丙烯酸酯微密封剂、银移植物、利福平 bonded 移植物、三氯生涂层缝线和术后伤口引流无有益效果。
- 内镜大隐静脉采集可能降低手术部位感染率(证据质量非常低)但可能降低长期通畅率;自体静脉移植物可能增加手术部位感染(证据质量非常低)但在膝上腹股沟下旁路术中可能提供更好的长期通畅率。
关键数值与推荐
- 预防性抗生素和负压伤口治疗:高质量证据支持。
- 庆大霉素胶原植入物:中等质量证据,限于高手术部位感染风险中心。
- 联合疗法、血糖控制、MRSA筛查、可吸收缝线:低或非常低质量证据。
- 营养补充、氯己定沐浴、备皮疗法、金黄色葡萄球菌鼻腔清除、氰基丙烯酸酯微密封剂、银移植物、利福平 bonded 移植物、三氯生涂层缝线、术后伤口引流:无有益效果证据。
- 内镜大隐静脉采集:非常低质量证据可能降低手术部位感染率但可能降低长期通畅率;自体静脉移植物:非常低质量证据可能增加手术部位感染但在膝上旁路术中可能提供更好长期通畅率。
临床怎么用
- 推荐使用预防性抗生素和术后负压伤口治疗以预防手术部位感染。
- 对于高手术部位感染风险中心,可考虑庆大霉素胶原植入物,但需注意证据质量为中等。
- 其他预防技术证据质量低或存在争议,应谨慎使用并个体化决策。
局限性
- 许多预防技术的文献存在显著偏倚风险。
- 需要进一步研究庆大霉素胶原植入物和特定联合疗法的疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This review aims to identify and review the current evidence for preventing postoperative surgical site infections in abdominal aortic aneurysm surgery or infrainguinal arterial surgery. METHODS: Extended literature review of clinical trials that examined the prevention of postoperative surgical site infections in abdominal aortic aneurysm or infrainguinal arterial surgery. Searches were conducted on Ovid MEDLINE (1950 - 13 March 2020) using key terms for vascular surgery, surgical site infections and specific preventative techniques. Articles were included if they discussed a relationship between a preventative technique and surgical site infections in abdominal aortic aneurysm or infrainguinal arterial surgery. The GRADE guidelines were used to assess the quality of evidence. RESULTS: 21 techniques and 81 studies were included. Prophylactic antibiotics and negative pressure wound therapy have a high quality of evidence for the prevention of surgical site infections in abdominal aortic aneurysm or infrainguinal arterial surgery. A moderate quality evidence base was identified for gentamicin containing collagen implant (confined to high surgical site infection risk centers). Currently, there is a low or very low quality of evidence to suggest a reduction in the surgical site infection rate for combination therapy, glycaemic control, Methicillin-resistant Staphylococcus aureus screening and absorbable suture. Evidence suggests no beneficial effect for nutritional supplementation, chlorhexidine bath, hair removal therapy, Staphylococcus aureus nasal eradication, cyanoacrylate microsealant, silver grafts, rifampicin bonded grafts, triclosan coated suture and postoperative wound drains. Endoscopic saphenous vein harvest may reduce surgical site infection rate (very low quality of evidence) but may lower long-term patency. Autologous vein grafts may increase surgical site infections (very low quality of evidence) but may provide better long-term patency rates in above-knee infrainguinal bypass surgery. There was no identified evidence for perioperative normothermia, electrosurgical bipolar vessel sealer or Dermabond and Tegaderm for surgical site infection prevention in vascular surgery. CONCLUSIONS: Prophylactic antibiotics and postoperative negative pressure wound therapy are effective in the prevention of postoperative surgical site infection in abdominal aortic aneurysm or infrainguinal arterial surgery. There exists a significant risk of bias in the literature for many preventative techniques and further studies are required to investigate the efficacy of gentamicin containing collagen implant, and specific combination therapies.
引用
- Zhao AH, Kwok CHR, Jansen SJ, et al. How to Prevent Surgical Site Infection in Vascular Surgery: A Review of the Evidence. Ann Vasc Surg. 2021. PMID: 34543711. doi:10.1016/j.avsg.2021.06.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。